Below are the most recent publications written about "Glycated Hemoglobin A" by people in Profiles.
-
Soriano EC, Lenhard MJ, Gonzalez JS, Tennen H, Otto AK, Perndorfer C, Shen BJ, Siegel SD, Laurenceau JP. Momentary Partner Involvement in Diabetes Self-Care and Continuously Measured Glucose: A Dynamic Analysis. Psychosom Med. 2022 09 01; 84(7):808-812.
-
Hu TY, Price J, Pierce JS, Gannon AW. The association between pediatric mental health disorders and type 1 diabetes-related outcomes. Pediatr Diabetes. 2022 06; 23(4):507-515.
-
Davies MJ, Rosenstock J, Ali A, Russell-Jones D, Souhami E, Palmer K, Ji C, Niemoeller E, Skolnik N. Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin =8%, =64?mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan-O randomized trial. Diabetes Obes Metab. 2022 01; 24(1):34-41.
-
Rising KL, Kemp M, Davidson P, Hollander JE, Jabbour S, Jutkowitz E, Leiby BE, Marco C, McElwee I, Mills G, Pizzi L, Powell RE, Chang AM. Assessing the impact of medically tailored meals and medical nutrition therapy on type 2 diabetes: Protocol for Project MiNT. Contemp Clin Trials. 2021 09; 108:106511.
-
Powell RE, Zaccardi F, Beebe C, Chen XM, Crawford A, Cuddeback J, Gabbay RA, Kissela L, Litchman ML, Mehta R, Meneghini L, Pantalone KM, Rajpathak S, Scribner P, Skelley JW, Khunti K. Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab. 2021 09; 23(9):2137-2154.
-
Dude AM, Badreldin N, Schieler A, Yee LM. Periconception glycemic control and congenital anomalies in women with pregestational diabetes. BMJ Open Diabetes Res Care. 2021 04; 9(1).
-
Riahi S, Lo KB, Anastasopoulou C, Rangaswami J. Insulin Use and Poor COVID-19 Outcomes among Diabetes Patients: Association Not Necessarily Causation. Endocr Res. 2021 Feb-May; 46(2):53-54.
-
Skolnik N, Del Prato S, Blonde L, Galstyan G, Rosenstock J. Translating iGlarLixi Evidence for the Management of Frequent Clinical Scenarios in Type 2 Diabetes. Adv Ther. 2021 04; 38(4):1715-1731.
-
Riahi S, Sombra LRS, Lo KB, Chacko SR, Neto AGM, Azmaiparashvili Z, Patarroyo-Aponte G, Rangaswami J, Anastasopoulou C. Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19. Endocr Res. 2021 Feb-May; 46(2):45-50.
-
Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J. Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline. Ann Intern Med. 2020 11 17; 173(10):813-821.